Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.480
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.36 billion as of July 31, 2026. Its market cap has decreased by -19.88% in one year.
Market Cap
1.36B
Enterprise Value
617.03M
Revenue
35.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.48
ChartMarket Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.36B, a decrease of -82.24%. That is a compound annual growth rate of -28.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.36B | -16.10% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.89B |
| AIM Vaccine | 1.70B |
| Mabpharm | 1.65B |
| HighTide Therapeutics | 1.43B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.26B |
| CANbridge Pharmaceuticals | 1.18B |